Treace Medical Concepts, Inc. Common Stock (TMCI) is a publicly traded Healthcare sector company. As of September 17, 2026, TMCI trades at $4.57 with a market cap of $296.56M and a P/E ratio of -4.90. TMCI moved -0.77% today. Year to date, TMCI is +81.20%; over the trailing twelve months it is -35.65%. Its 52-week range spans $1.17 to $10.79. Analyst consensus is moderatebuy with an average price target of $5.50. Rallies surfaces TMCI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TMCI insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $4.57 |
| Market Cap | $296.56M |
| P/E Ratio | -4.90 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.79 |
| 52-Week Low | $1.17 |
| Volume | 162.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $205.31M |
| Net Income | $-59.52M |
| Gross Margin | 79.45% |
3 analysts cover TMCI: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $5.50.